Neoadjuvant Toripalimab and Radiotherapy Treatment in N+ HR+ Breast Cancer

NCT06671262 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Breast Adenocarcinoma

Interventions

RADIATION: SBRT
DRUG: Immuno-chemotherapy

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University